Ftse Mib
34.375,92
0,00%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
64.001,01
-1,31%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ (MM) (RCPT) (MM) (RCPT) Notizie

RCPT

RECEPTOS, INC. (RCPT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RCPT
DataOraFonteTitoloSimboloCompagnia
15/07/201500:37Dow Jones NewsCelgene to Buy Receptos for About $7.2 Billion--2nd UpdateNASDAQ:RCPT(MM)
15/07/201500:18Dow Jones NewsCelgene to Buy Receptos for About $7.2 Billion--UpdateNASDAQ:RCPT(MM)
14/07/201523:50Dow Jones NewsCelgene to Buy Receptos for About $7.2 BillionNASDAQ:RCPT(MM)
14/07/201523:46Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Receptos, Inc. of Commencement of an Investigation Concerni...NASDAQ:RCPT(MM)
14/07/201523:28Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:RCPT(MM)
14/07/201523:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
14/07/201522:58Business WireCelgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory DiseasesNASDAQ:RCPT(MM)
13/07/201515:55The Motley Fool5 Drugs That Investors May Be UndervaluingNASDAQ:RCPT(MM)
02/07/201518:11The Motley FoolWhy Shares in Receptos Soared 15% in JuneNASDAQ:RCPT(MM)
12/06/201500:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RCPT(MM)
11/06/201522:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RCPT(MM)
02/06/201515:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:RCPT(MM)
15/05/201514:00GlobeNewswire Inc.Receptos Announces Oral Plenary Presentation of TOUCHSTONE Phase 2 Induction Data at Digestive Disease Week 2015NASDAQ:RCPT(MM)
14/05/201514:00GlobeNewswire Inc.Receptos to Present at UBS Global Healthcare ConferenceNASDAQ:RCPT(MM)
07/05/201514:00GlobeNewswire Inc.Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare ConferenceNASDAQ:RCPT(MM)
06/05/201522:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RCPT(MM)
06/05/201516:28Analyst Ratings NetworkReceptos PT Raised to $202.00 (RCPT)NASDAQ:RCPT(MM)
05/05/201522:01GlobeNewswire Inc.Receptos Provides Business Update and Reports First Quarter 2015 Financial ResultsNASDAQ:RCPT(MM)
29/04/201514:00GlobeNewswire Inc.Receptos to Hold First Quarter 2015 Results Conference CallNASDAQ:RCPT(MM)
19/04/201517:07The Motley Fool3 Biotech Stocks That Could Be Developing Billion Dollar DrugsNASDAQ:RCPT(MM)
17/04/201522:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RCPT(MM)
17/04/201522:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RCPT(MM)
16/04/201514:00GlobeNewswire Inc.Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Coliti...NASDAQ:RCPT(MM)
01/04/201523:25The Motley FoolWhy Receptos, Inc. Shares Soared Higher TodayNASDAQ:RCPT(MM)
01/04/201514:00GlobeNewswire Inc.Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple SclerosisNASDAQ:RCPT(MM)
09/03/201513:00GlobeNewswire Inc.Receptos to Present at Barclays Global Healthcare ConferenceNASDAQ:RCPT(MM)
03/03/201522:01GlobeNewswire Inc.Receptos Provides Development Updates and Reports Fourth Quarter and Year End 2014 Financial ResultsNASDAQ:RCPT(MM)
02/03/201513:57Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RCPT(MM)
26/02/201514:00GlobeNewswire Inc.Receptos to Hold Fourth Quarter and Year End 2014 Financial Results Conference CallNASDAQ:RCPT(MM)
18/02/201514:00GlobeNewswire Inc.Receptos Announces Oral Podium Presentation at Annual Meeting of European Crohn's and Colitis Organization (ECCO)NASDAQ:RCPT(MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RCPT

La tua Cronologia

BIT
P1MG67
BNP Paribas Issuance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network